Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/14309
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Aspirin: How low is low dose? |
Author: | Lloyd, J. Bochner, F. |
Citation: | Australian Prescriber, 1996; 19(3):79-81 |
Publisher: | Australian Prescriber |
Issue Date: | 1996 |
ISSN: | 0312-8008 1839-3942 |
Statement of Responsibility: | John Lloyd, Felix Bochner |
Abstract: | Aspirin reduces the risk of non-fatal stroke, non-fatal myocardial infarction and vascular death in patients at high risk of arterial thrombosis. Platelet function is inhibited by doses of 40-160 mg daily. In clinical trials performed before 1985, doses of 500-1500 mg daily were found to be effective. Since 1985, low doses have been evaluated and a meta-analysis has shown that daily doses of 75-150 mg are as effective as the previously used higher doses. The risk of adverse effects is dose-dependent above 75 mg daily. The maximum benefit:risk ratio is likely to be achieved with doses of 75-150 mg daily. In Australia, this is best achieved by either a single 100 mg tablet or half a 300 mg tablet taken daily. |
Keywords: | formulation clinical trials adverse effects platelet function |
DOI: | 10.18773/austprescr.1996.070 |
Published version: | http://www.australianprescriber.com/magazine/19/3/79/81/ |
Appears in Collections: | Aurora harvest 2 Pharmacology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.